References
- Taylor SR, Isa H, Joshi L, Lightman S. New developments in corticosteroid therapy for uveitis. Ophthalmologica 2010;224(Suppl 1):46–53.
- Sheyman AT, Cohen BZ, Friedman AH, Ackert JM. An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone. JAMA Ophthalmol 2013;131:864–869.
- Jaffe GJ, Ben-Nun J, Guo H, Dunn JP, Ashton P. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. Ophthalmology 2000;107:2024–2033.
- Shikamura Y, Yamazaki Y, Matsunaga T, Sato T, Ohtori A, Tojo K. Hydrogel ring for topical drug delivery to the ocular posterior segment. Curr Eye Res 2015;1–9.
- McDonald, TM., Shadduck, JA. Eye irritation. In: Marzulli FN, Maibach HI (Eds.) Dermatotoxicology and Pharmacology, vol. 4. Washington, DC: Hemisphere; 1977:139–191.
- Eljarrat-Binstock E, Pe’er J, Domb AJ. New techniques for drug delivery to the posterior eye segment. Pharm Res 2010;27:530–543.
- Hull DS, Edelhauser HF, Hyndiuk RA. Ocular penetration of prednisolone and the hydrophilic contact lens. Arch Ophthalmol 1974;92:413–416.
- Podos SM, Becker B, Asseff C, Hartstein J. Pilocarpine therapy with soft contact lenses. Am J Ophthalmol 1972;73:336–341.
- dos Santos JF, Alvarez-Lorenzo C, Silva M, Balsa L, Couceiro J, Torres-Labandeira JJ, et al. Soft contact lenses functionalized with pendant cyclodextrins for controlled drug delivery. Biomaterials 2009;30:1348–1355.
- dos Santos JF, Couceiro R, Concheiro A, Torres-Labandeira JJ, Alvarez-Lorenzo C. Poly(hydroxyethyl methacrylate-co-methacrylated-beta-cyclodextrin) hydrogels: synthesis, cytocompatibility, mechanical properties and drug loading/release properties. Acta Biomater 2008;4:745–755.
- Ciolino JB, Stefanescu CF, Ross AE, Salvador-Culla B, Cortez P, Ford EM, et al. In vivo performance of a drug-eluting contact lens to treat glaucoma for a month. Biomaterials 2014;35:432–439.
- Peng CC, Burke MT, Carbia BE, Plummer C, Chauhan A. Extended drug delivery by contact lenses for glaucoma therapy. J Control Release 2012;162:152–158.
- Hehl EM, Beck R, Luthard K, Guthoff R, Drewelow B. Improved penetration of aminoglycosides and fluorozuinolones into the aqueous humour of patients by means of Acuvue contact lenses. Eur J Clin Pharmacol 1999;55:317–323.
- Busin M, Spitznas M. Sustained gentamicin release by presoaked medicated bandage contact lenses. Ophthalmology 1988;95:796–798.
- Hillman JS. Management of acute glaucoma with pilocarpine-soaked hydrophilic lens. Br J Ophthalmol 1974;58:674–679.
- Hiratani H, Fujiwara A, Tamiya Y, Mizutani Y, Alvarez-Lorenzo C. Ocular release of timolol from molecularly imprinted soft contact lenses. Biomaterials 2005;26:1293–1298.
- Tieppo A, White CJ, Paine AC, Voyles ML, McBride MK, Byrne ME. Sustained in vivo release from imprinted therapeutic contact lenses. J Control Release 2012;157:391–397.
- Kakisu K, Matsunaga T, Kobayakawa S, Sato T, Tochikubo T. Development and efficacy of a drug-releasing soft contact lens. Invest Ophthalmol Vis Sci 2013;54:2551–2561.
- Hunter RS, Lobo AM. Dexamethasone intravitreal implant for the treatment of noninfectious uveitis. Clin Ophthalmol 2011;5:1613–1621.
- Jaffe GJ, Martin D, Callanan D, Pearson PA, Levy B, Comstock T, et al. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. Ophthalmology 2006;113:1020–1027.
- Jaffe GJ, McCallum RM, Branchaud B, Skalak C, Butuner Z, Ashton P. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. Ophthalmology 2005;112:1192–1198.
- Lowder C, Belfort R, Jr., Lightman S, Foster CS, Robinson MR, Schiffman RM, et al. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol 2011;129:545–553.
- Tan DT, Chee SP, Lim L, Lim AS. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation. Ophthalmology 1999;106:223–231.
- Allen RC, Suhler EB, Flaxel CJ, Chen Z, Choi D. Long-term follow-up of patients treated with multiple fluocinolone acetonide implants for noninfectious uveitis. J Ophthalmic Inflamm Infect 2012;2:177–182.
- Bollinger K, Kim J, Lowder CY, Kaiser PK, Smith SD. Intraocular pressure outcome of patients with fluocinolone acetonide intravitreal implant for noninfectious uveitis. Ophthalmology 2011;118:1927–1931.
- Friedman DS, Holbrook JT, Ansari H, Alexander J, Burke A, Reed SB, et al. Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial. Ophthalmology 2013;120:1571–1579.